Strengths

● The stock, which is currently worth 2019 to 0.65 times its sales, is clearly overvalued in comparison with peers.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.


Weaknesses

● The company has insufficient levels of profitability.

● The group shows a rather high level of debt in proportion to its EBITDA.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The company's earnings releases usually do not meet expectations.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● Revenue estimates are regularly revised downwards for the current and coming years.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● The underlying tendency is negative on the weekly chart below the resistance at 2.11 CAD